EMMA WEBER: Open Payments
NPI 1962058370 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 71 payments from 17 companies in 2025. Trend: 2023 $1,359 · 2024 $1,401 · 2025 $1,181
Food & beverage: $1,174Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $182 |
| Novartis Pharmaceuticals Corporation | 10 | $160 |
| Regeneron Healthcare Solutions, Inc. | 11 | $155 |
| Lilly USA, LLC | 5 | $98 |
| GENZYME CORPORATION | 4 | $94 |
| PFIZER INC. | 4 | $71 |
| Arcutis Biotherapeutics, Inc. | 4 | $70 |
| Incyte Corporation | 3 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Janssen Biotech, Inc. | 2 | $41 |
Products named: DUPIXENT, COSENTYX, SKYRIZI, TALTZ, CIBINQO, Zoryve, RINVOQ, OPZELURA.
Industry payments across MD — which companies pay providers there.
